FDA Adverse Event Other Summary report: N

BRACANALYSIS

MDR report key: 1560588 · Received December 10, 2009

Report

Report Number
MW5013962
Event Type
Other
Date Received
December 10, 2009
Date of Event
September 16, 2009
Report Date
December 10, 2009
Manufacturer
MYRIAD GENETIC LABORATORIES, INC
Product Code
OQS
Report Source
Voluntary report
Reporter Location
CT, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Description of Event or Problem · 1

THIS IS AN UNAFFECTED FEMALE PT. HER SISTER WAS DIAGNOSED WITH BILATERAL BREAST CANCER, AND WAS FOUND TO CARRY A BRCA1 MUTATION. THIS PT'S GYNECOLOGIST REFERRED HER TO AN ONCOLOGIST FOR GENETIC TESTING. SHE HAD LITTLE OR NO PRE-TEST COUNSELING. BRCA TESTING WAS ORDERED, AND THE PT WAS FOUND TO CARRY THE FAMILIAL BRCA1 MUTATION. DURING A DISCUSSION OF THE SURVEILLANCE AND RISK REDUCTION OPTIONS, THE PT REPORTS THAT THE ONCOLOGIST DESCRIBED THE OPTION OF PROPHYLACTIC MASTECTOMY AS "CHOPPING OFF THE BREAST." SHE LEFT THE APPOINTMENT WITH THE ONCOLOGIST FEELING FRIGHTENED AND CONFUSED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 BRACANALYSIS BRCA1 GENE TESTING OQS MYRIAD GENETIC LABORATORIES, INC
2 BRACANALYSIS BRCA2 GENE TESTING ODJ MYRIAD GENETIC LABORATORIES, INC

Patients

Seq Age Sex Outcome Treatment
1 42 YR